Table 4.
MIPS Bincodea | MIPS Annotation categoryb | BHLHc | BZIPd | HSFe | NACf | WRKYg | AP2 (CBF)h | DOFi | MYBj | MADSk | TCP2l | AP2 (AtERF)m |
01 | METABOLISM | 10-2 | 10-1 | 10-1 | 101 | 101 | 10-1 | 10-1 | 10-1 | 10-1 | 10-1 | 101 |
01.01.03 | Assimilation of ammonia, metabolism of the glutamate group | 10-2 | N/A | N/A | N/A | N/A | N/A | 10-1 | 10-1 | N/A | N/A | N/A |
01.03.04.03 | Pyrimidine nucleotide anabolism | 10-2 | N/A | N/A | N/A | N/A | N/A | 10-1 | N/A | N/A | N/A | N/A |
01.05 | C-compound and carbohydrate metabolism | 10-1 | 10-2 | 10-1 | 101 | 10-1 | 101 | 10-2 | 10-1 | 10-1 | N/A | N/A |
01.05.01.03 | C-compound, carbohydrate anabolism | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 10-2 | N/A | N/A |
01.05.01.03.02 | Polysaccharide biosynthesis | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 10-2 | N/A | N/A |
01.06 | Lipid, fatty acid and isoprenoid metabolism | 10-1 | 101 | N/A | 10-1 | N/A | 10-1 | 10-1 | 101 | N/A | 10-2 | N/A |
01.06.01.01 | Phospholipid biosynthesis | N/A | 10-2 | N/A | 10-2 | N/A | 10-2 | 101 | N/A | N/A | N/A | N/A |
01.06.04 | Degradation of lipids, fatty acids and isoprenoids | 10-3 | N/A | N/A | 10-1 | N/A | N/A | 10-2 | N/A | N/A | 10-2 | N/A |
01.20.17 | Biosynthesis of secondary products derived from primary amino acids | 10-3 | N/A | 10-1 | 10-1 | N/A | N/A | 10-1 | 10-2 | N/A | N/A | N/A |
01.20.17.01 | Biosynthesis of nonprotein amino acids | 10-1 | N/A | N/A | N/A | N/A | N/A | 10-1 | 10-2 | N/A | N/A | N/A |
01.20.17.09 | Biosynthesis of alkaloids | 10-1 | N/A | N/A | 10-1 | N/A | N/A | 10-1 | 10-2 | N/A | N/A | N/A |
01.20.35 | Biosynthesis of secondary products derived from L-phenylalanine and L-tyrosine | N/A | N/A | 10-1 | N/A | 10-1 | 10-1 | 101 | N/A | N/A | N/A | 10-2 |
01.20.35.01 | Biosynthesis of phenylpropanoids | N/A | N/A | 10-1 | N/A | 10-1 | 10-1 | 101 | N/A | N/A | N/A | 10-2 |
02 | ENERGY | 10-1 | 10-3 | 10-2 | 101 | 101 | 10-1 | 10-2 | 10-1 | N/A | N/A | N/A |
02.13 | Respiration | 10-1 | 10-2 | N/A | 10-1 | N/A | N/A | 10-1 | 10-1 | N/A | N/A | N/A |
02.13.03 | Aerobic respiration | 10-1 | 10-1 | N/A | 10-1 | N/A | N/A | 10-2 | N/A | N/A | N/A | N/A |
02.19 | Metabolism of energy reserves (e.g. glycogen, trehalose) | 10-1 | 10-4 | 10-2 | 10-1 | N/A | N/A | 10-1 | N/A | N/A | N/A | N/A |
04 | STORAGE PROTEIN | N/A | N/A | N/A | N/A | N/A | N/A | 10-1 | N/A | N/A | N/A | 10-2 |
10.01 | DNA processing | 10-1 | 10-2 | 101 | N/A | 10-1 | N/A | 10-1 | N/A | N/A | N/A | N/A |
10.03.04.03 | Chromosome condensation | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | TRANSCRIPTION | 10-1 | 10-2 | 10-2 | 10-3 | 10-4 | 10-1 | 10-4 | 101 | 10-1 | N/A | 10-1 |
11.02 | RNA synthesis | 10-1 | 10-2 | 10-2 | 10-4 | 10-5 | 10-1 | 10-4 | 10-1 | 10-1 | N/A | 10-1 |
11.02.01 | rRNA synthesis | N/A | N/A | 10-2 | 10-1 | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A |
11.02.03 | mRNA synthesis | 10-1 | 10-2 | 10-2 | 10-3 | 10-4 | 10-1 | 10-4 | 10-1 | 10-1 | N/A | 10-1 |
11.02.03.04 | Transcriptional control | 10-1 | 10-2 | 10-1 | 10-3 | 10-3 | 10-1 | 10-3 | 101 | 10-1 | N/A | 10-1 |
11.04 | RNA processing | 101 | 10-1 | 10-3 | 10-2 | 10-2 | 10-2 | 10-1 | 10-1 | N/A | N/A | N/A |
11.04.01 | rRNA processing | N/A | N/A | 10-3 | 10-1 | 10-2 | 10-3 | N/A | N/A | N/A | N/A | N/A |
11.04.02 | tRNA processing | N/A | 10-2 | N/A | N/A | N/A | N/A | 10-1 | N/A | N/A | N/A | N/A |
11.04.03 | mRNA processing (splicing, 5'-, 3'-end processing) | 10-1 | N/A | 10-2 | 10-2 | 10-1 | 10-1 | 10-1 | 10-1 | N/A | N/A | N/A |
11.04.03.01 | Splicing | 10-1 | N/A | 10-1 | 10-2 | 10-1 | 10-1 | 10-1 | 10-2 | N/A | N/A | N/A |
12.04.03 | Translation termination | 10-2 | N/A | N/A | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16.03.01 | DNA binding | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16.13 | C-compound binding | N/A | N/A | 10-1 | N/A | 10-2 | N/A | 10-1 | N/A | N/A | N/A | N/A |
18 | PROTEIN ACTIVITY REGULATION | N/A | 10-1 | 10-1 | 10-1 | 10-2 | 10-1 | 10-1 | N/A | N/A | N/A | N/A |
18.01.01 | Modification | N/A | N/A | 10-1 | N/A | 10-2 | N/A | 10-1 | N/A | N/A | N/A | N/A |
18.02.05 | Regulator of G-protein signalling | N/A | 10-2 | N/A | 10-2 | 10-2 | 10-2 | 10-1 | N/A | N/A | N/A | N/A |
20 | CELLULAR TRANSPORT, TRANSPORT FACILITATION AND TRANSPORT ROUTES | 10-2 | 101 | 101 | 10-1 | N/A | 101 | 10-1 | 10-1 | 10-1 | N/A | N/A |
20.01 | Transported compounds (substrates) | 10-2 | 101 | 101 | 10-1 | N/A | 10-1 | 10-2 | 10-1 | N/A | N/A | N/A |
20.01.01 | Ion transport | 10-1 | N/A | 101 | 101 | N/A | 10-1 | 10-2 | 10-1 | N/A | N/A | N/A |
20.01.03 | C-compound and carbohydrate transport | 10-1 | N/A | 10-1 | 10-2 | N/A | 10-2 | N/A | 10-1 | N/A | N/A | N/A |
20.09.07 | Vesicular transport (Golgi network, etc.) | 10-2 | 10-1 | N/A | 10-1 | N/A | N/A | 10-1 | N/A | 10-1 | N/A | N/A |
30.05.01.10 | Two-component signal transduction system (sensor kinase component) | N/A | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | CELL RESCUE, DEFENSE AND VIRULENCE | 10-1 | 101 | 10-2 | 10-2 | 10-2 | 10-4 | 10-2 | 10-1 | N/A | N/A | 10-1 |
32.01 | Stress response | 10-2 | 101 | 10-3 | 10-2 | 101 | 10-4 | 10-2 | 10-1 | N/A | N/A | 10-1 |
32.05 | disease, virulence and defense | 101 | 101 | 101 | 10-1 | 10-2 | 10-1 | 10-1 | 10-1 | N/A | N/A | N/A |
32.05.03 | defense related proteins | N/A | 10-1 | 10-1 | 10-1 | 10-3 | 10-3 | 10-1 | 10-1 | N/A | N/A | N/A |
36.25.16 | Immune response | N/A | N/A | 10-1 | N/A | 10-2 | N/A | 10-1 | N/A | N/A | N/A | N/A |
40 | CELL FATE | 10-2 | 101 | N/A | 101 | N/A | 10-1 | 10-1 | 101 | N/A | N/A | N/A |
40.20 | Cell aging | 10-3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
41.05.10 | Late embryonic development | N/A | N/A | N/A | 10-2 | N/A | 10-2 | N/A | N/A | N/A | N/A | N/A |
42.02 | Eukaryotic plasma membrane | N/A | 10-2 | N/A | 10-1 | 10-2 | 10-1 | N/A | N/A | N/A | N/A | N/A |
42.10 | Nucleus | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
42.10.03 | Organization of chromosome structure | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
70 | SUBCELLULAR LOCALIZATION | 10-2 | 10-2 | 10-1 | 101 | 10-1 | 101 | 10-1 | 101 | 101 | N/A | 10-1 |
70.01 | Cell wall | 10-1 | N/A | N/A | 10-2 | 10-1 | 10-1 | 10-1 | N/A | N/A | N/A | N/A |
70.08 | Golgi | 10-1 | N/A | N/A | N/A | N/A | N/A | 10-1 | N/A | 10-2 | N/A | N/A |
70.09 | Intracellular transport vesicles | 10-2 | 10-1 | N/A | 10-1 | N/A | N/A | 10-2 | N/A | N/A | N/A | N/A |
70.10 | Nucleus | 101 | 10-3 | 10-1 | 101 | 10-2 | 10-1 | 101 | N/A | N/A | N/A | 10-1 |
70.10.03 | Chromosome | 10-1 | 10-2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
73.03.09 | Immune cell | N/A | N/A | 10-2 | N/A | 10-2 | N/A | 10-2 | N/A | N/A | N/A | N/A |
98 | CLASSIFICATION NOT YET CLEAR-CUT | 10-1 | 10-3 | 10-3 | 10-3 | 10-2 | 10-3 | 10-4 | 10-1 | 10-1 | 10-1 | 10-1 |
Significant functional annotations of the cluster of genes putatively regulated by the TF-encoding genes. a and b: annotation categories in the MIPS functional annotation database. c to m: p-values obtained for all the genes putatively regulated by the corresponding TF. The significance of the annotation (p) for the list of all target genes putatively regulated by a TF was calculated using the MIPS online interface. Entries in bold denote significant annotations (p < 0.05).